v3.26.1
Stockholders' Equity
6 Months Ended
Jun. 30, 2026
Stockholders' Equity  
Stockholders' Equity

Note 8 – Stockholders’ Equity

Common Stock

Stock options exercised for common stock and shares of common stock issued upon vesting of restricted stock units (“RSUs”) for the three and six months ended June 30, 2026 and 2025 are summarized in the table below.

Three Months Ended June 30, 

Six Months Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

2026

  ​ ​ ​

2025

Stock options exercised

350,757

42,494

1,883,177

Shares of common stock issued under the ESPP

151,197

180,091

151,197

180,091

Shares of common stock issued for vested RSUs

2,546,622

1,096,546

3,035,356

1,648,374

Shares of common stock repurchased

(3,361,396)

(3,361,396)

The table below presents the cash received or paid associated with common stock related activities for the three and six months ended June 30, 2026 and 2025.

Three Months Ended June 30, 

Six Months Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

  ​ ​ ​

2025

Cash received from stock options exercised

$

$

478

$

6

$

659

Cash received from shares of common stock issued under the ESPP

370

156

370

156

Cash paid for shares of common stock repurchased

(3,592)

(3,592)


At-the-Market Offering

On September 5, 2025, the Company entered into an Equity Distribution Agreement (the “Distribution Agreement”) with Oppenheimer & Co. Inc., serving as agent (“Oppenheimer”), with respect to an at-the-market offering program (the “ATM”) under which the Company may offer and sell, from time to time, shares of its common stock having an aggregate offering price of up to $150,000 through Oppenheimer. During the three and six months ended June 30, 2026, the Company did not sell any shares of common stock under the Distribution Agreement. As of June 30, 2026, approximately $58,785 remained available for future sales under the Distribution Agreement.

Registered Direct Offering

On January 28, 2026, the Company entered into a securities purchase agreement with a single sector-focused institutional investor for the direct offering of 17,000,000 shares of its common stock, Pre-Funded Warrants to purchase an aggregate of 5,807,018 shares of common stock, and Common Warrants to purchase up to an aggregate of 45,614,036 shares of common stock. The common stock was purchased at a price of $5.70 per share of common stock and accompanying two Common Warrants and the Pre-Funded Warrants were purchased at a price of $5.6999 per Pre-Funded Warrant and accompanying two Common Warrants. The Common Warrants issued are immediately exercisable at an exercise price of $7.25 per share and will expire on January 31, 2033. Proceeds, net of fees and expenses, received by the Company totaled $121,345. Issuance costs totaled $8,654 and are recorded in additional paid-in capital. The Company intends to use the net proceeds from the registered direct offering for working capital and general corporate purposes. As of June 30, 2026, all Pre-Funded Warrants have been exercised and all proceeds to the Company are recorded in additional paid-in capital.

Stock Repurchase Program

On January 23, 2024, the Company announced that its Board of Directors approved a stock repurchase program (“Program”) authorizing the Company to purchase up to $50,000 of the Company’s outstanding common stock. The Program expired on December 31, 2025.

The table below presents the number of shares repurchased and retired, the principal, commissions, and total cash paid to repurchase and retire shares of common stock, the excise tax, and the average purchase price per share for the three and six months ended June 30, 2025:

Three Months Ended June 30, 

Six Months Ended June 30, 

  ​ ​ ​

2025

2025

Repurchased and retired shares of common stock

3,361,396

3,361,396

Principal paid to repurchase and retire shares of common stock

3,525

3,525

Commissions paid to repurchase and retire shares of common stock

67

67

Total cash paid to repurchase and retire shares of common stock

(3,592)

(3,592)

Excise tax accrued

35

35

Average price paid per share (including commissions)

$

1.07

$

1.07